Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medical device cancellation (827)
- Medicine suspension (472)
- Complementary medicine cancellation (203)
- Medical device suspension (86)
- Medicine cancellation (59)
- Revocation of a TGA issued Conformity Assessment Certificate (51)
- Medical device cancellation - certain devices within an entry (22)
- Registered medicine cancellation (12)
- Voluntary revocation at the request of the manufacturer (9)
- Medical device cancellation - requested by the sponsor - certain devices within an entry (8)
- Medical device cancellation (7)
- Listed medicine cancellation (3)
- Listed medicine cancellation (3)
- Revocation of a TGA issued Conformity Assessment Certificate. (3)
- Revocation of medical device suspension (2)
- Revoked medicine suspension (2)
- Medical device cancellation (1)
- Medical device cancellation – certain devices within an entry (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
- Voluntary revocation at the request of the manufacturer. (1)
Find out more about Cancellations and Suspensions.
Results for
"[search-keyword]"
Search
1780 result(s) found, displaying 1601 to 1625
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply with a condition of listing under s.28(5B)(a) of the Act (that each step in the manufacture of the medicine that is carried out in Australia is carried out by a person who is the holder of a licence to carry out that step).The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 23/02/2016
-
Cancellation or suspensionRegulatory action due to It appeared to the Secretary that the presentation of the goods was unacceptable.The goods have changed so they have become separate and distinct from the goods included in the ARTG.As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(j) was incorrect. The goods do not conform to a standard applicable to the goods., effective 05/02/2016
-
Dressing, hydrogel (Cancelled from the ARTG under s. 41GL(d) and the ARTG entry varied under s.41GO)
Cancellation or suspensionRegulatory action due to The sponsor requested in writing the cancellation of these devices from the ARTG entry., effective 02/02/2016 -
Cancellation or suspensionRegulatory action due to The sponsor failed to comply within 20 working days after a notice was given under section 31 requiring it to provide information or documents about the certifications made in relation to the goods., effective 29/01/2016
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(j) was incorrect. The goods do not conform to a standard applicable to the goods., effective 22/01/2016
-
Cancellation or suspensionRegulatory action due to The goods were not eligible for listing as they contained a substance which is not permitted by Schedule 4 of the Therapeutic Goods Regulations., effective 18/01/2016
-
Cancellation or suspensionRegulatory action due to The goods were not eligible for listing as they contained a substance which is not permitted by Schedule 4 of the Therapeutic Goods Regulations., effective 18/01/2016
-
Cancellation or suspensionRegulatory action due to As there was insufficient evidence to support the indications for the product, the certification made under s.26A(2)(j) was incorrect.The applicable provisions of the Therapeutic Goods Advertising Code have not been complied with., effective 21/12/2015
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply within 20 working days after a notice was given under section 31 requiring it to provide information or documents about the certifications made in relation to the goods., effective 10/12/2015
-
Cancellation or suspensionRegulatory action due to The sponsor failed to comply within 20 working days after a notice was given under section 31 requiring it to provide information or documents about the certifications made in relation to the goods., effective 30/11/2015
-
Cancellation or suspensionRegulatory action due to The goods were not eligible for listing as they contained a substance which is not permitted by Schedule 4 of the Therapeutic Goods Regulations., effective 23/11/2015
-
Cancellation or suspensionRegulatory action due to As the devices do not comply with Essential Principle 7.2 (1), the certifications made under s.41FD(d)are no longer correct. As this is grounds for cancellation of an ARTG entry under s. 41GN(1)(f) of the Act (and thus grounds for suspension), the Secretary has proposed to suspended the entries for a period not exceeding 6 months., effective 20/11/2015